Beryl Drugs share news, announcements and annual reports
BSE: 524606Pharmaceuticals & BiotechnologySmall Cap
Share price at the BSE close on 30 Oct 2026. Previous close ₹25.00.
30 Oct: open ₹27.00, high ₹27.00, low ₹23.00
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies. Market capitalisation: how it is worked out
- ₹13 Cr4,587th largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. Price to earnings, trailing: how it is worked out
- 20.79
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. Price to book: how it is worked out
- 1.31
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- Nonein the last 12 months
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it.
- 6.4%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet.
- 3.1%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026.
- 0.24
- Volume, BSEVolume. Shares traded on the last trading day. Volume in the glossary
- 2,166
Beryl Drugs share news and announcements
572 announcements, routine notices left out, newest first. Page 6 of 12.
Sep 2021
3 Sep · Meeting
Aug 2021
25 Aug · Board meeting
Meeting on 3 Sep 2021: annual general meeting11 Aug · Results
5 Aug · Board meeting
Meeting on 11 Aug 2021: quarterly results
Jul 2021
20 Jul · Shareholding for the Period Ended June 30, 2021
Shareholding Pattern for the Period Ended June 30, 2021. For more details, kindly Click ....20 Jul · Announcement under Regulation 30 (LODR)-Demise
9 Jul · Statement Of Investor Complaints For The Quarter Ended June 2021
No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0 0 0 0
Jun 2021
30 Jun · Board meeting
22 Jun · Board meeting
Meeting on 30 Jun 2021: audited results
Apr 2021
20 Apr · Shareholding for the Period Ended March 31, 2021
Shareholding Pattern for the Period Ended March 31, 2021. For more details, kindly Click ....19 Apr · Reg 40(10)- PCS Certificate For Transfer/ Transmission/ Transposition
8 Apr · Statement Of Investor Complaints For The Quarter Ended March 2021
No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0 0 0 0
Feb 2021
4 Feb · Board meeting
Meeting on 12 Feb 2021: quarterly results
Jan 2021
13 Jan · Shareholding for the Period Ended December 31, 2020
Shareholding Pattern for the Period Ended December 31, 2020. For more details, kindly Click ....7 Jan · Statement Of Investor Complaints For The Quarter Ended December 2020
No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0 0 0 0
Dec 2020
25 Dec · Results
Details of Voting results of AGM, under Regulation 44(3) of SEBI (LODR) Regulations, 2015. Kindly ....25 Dec · Disclosure Under Regulation 44 Of LODR
24 Dec · Meeting
23 Dec · Meeting
Nov 2020
30 Nov · Reg. 34 (1) Annual Report
30 Nov · Meeting
20 Nov · Board meeting
Meeting on 20 Nov 202011 Nov · Meeting
11 Nov · Board meeting
11 Nov · Board meeting
5 Nov · Board meeting
Meeting on 11 Nov 2020: quarterly results and annual general meeting
Oct 2020
20 Oct · Shareholding for the Period Ended September 30, 2020
Shareholding Pattern for the Period Ended September 30, 2020. For more details, kindly Click ....9 Oct · COMPLIANCE- COMPLIANCE CERTIFICATE UNDER REGULATION 7(3) FOR THE QUARTER ENDED 30TH SEPTEMBER, 2020